Ambuja Cements (AMBUJACEM) — Corporate Action

Ambuja Cements Limited announced an NCLT-ordered shareholder meeting scheduled for November 20, 2025 to approve a Scheme of Arrangement with Sanghi Industries Limited. Remote e-voting opens November 15–19, 2025. Shareholder approval requires a three-fourths majority of equity shareholders plus majority support from public shareholders. The transaction is governed under Companies Act Sections 230–232. Regulatory approvals from NCLT (Ahmedabad Bench) were obtained in late September and early October 2025.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this corporate action affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 16 October 2025?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 16 October 2025

BAJFINANCE Bajaj Finance Limited Announcement WIPRO Wipro Limited Financial Results WIPRO Wipro Limited Financial Results SBICARD SBI Cards and Payment Services Limited Announcement AXISBANK Axis Bank Limited Financial Results CANBK Canara Bank Offer Document

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.